These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 3042251)

  • 1. The natural history of brittle diabetes.
    Williams G; Pickup JC
    Diabetes Res; 1988 Jan; 7(1):13-8. PubMed ID: 3042251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4-year follow-up.
    Sulli N; Shashaj B
    Diabet Med; 2006 Aug; 23(8):900-6. PubMed ID: 16911629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of diabetes care, diabetes knowledge and risk of severe hypoglycaemia one and four years after participation in a 5-day structured treatment and teaching programme for intensified insulin therapy.
    Schiel R; Ulbrich S; Müller UA
    Diabetes Metab; 1998 Dec; 24(6):509-14. PubMed ID: 9932217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brittle diabetes characterised by recurrent hypoglycaemia.
    Gill G; Lucas S
    Diabetes Metab; 1999 Sep; 25(4):308-11. PubMed ID: 10566119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life and treatment satisfaction in adults with Type 1 diabetes: a comparison between continuous subcutaneous insulin infusion and multiple daily injections.
    ; Nicolucci A; Maione A; Franciosi M; Amoretti R; Busetto E; Capani F; Bruttomesso D; Di Bartolo P; Girelli A; Leonetti F; Morviducci L; Ponzi P; Vitacolonna E
    Diabet Med; 2008 Feb; 25(2):213-20. PubMed ID: 18201210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous intraperitoneal insulin infusion partly restores the glucagon response to hypoglycaemia in type 1 diabetic patients.
    Oskarsson PR; Lins PE; Backman L; Adamson UC
    Diabetes Metab; 2000 Apr; 26(2):118-24. PubMed ID: 10804326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
    Bode BW
    Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscle infarction in a young woman with brittle type 1 diabetes.
    Virally M; Laloi-Michelin M; Médeau V; Meas T; Kévorkian JP; Mouly S; Guillausseau PJ
    Diabetes Metab; 2007 Dec; 33(6):466-8. PubMed ID: 18024110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Assessment of metabolic control and safety of continuous subcutaneous insulin infusion in prepubertal children with type 1 diabetes mellitus].
    Minkina-Pedras M; Jarosz-Chobot P; Małecka-Tendera E; Deja G
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(3):171-6. PubMed ID: 16232370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin pumps--still a research tool?
    Lauritzen T; Pramming S
    Ann Clin Res; 1984; 16(2):98-106. PubMed ID: 6380393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-mediated glucose disposal in type 1 (insulin-dependent) diabetic subjects treated by continuous subcutaneous or intraperitoneal insulin fusion.
    Beylot M; Khalfallah Y; Laville M; Sautot G; Dechaud H; Serusclat P; Berthezene F; Riou JP; Mornex R
    Diabete Metab; 1987; 13(4):450-6. PubMed ID: 3315766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous intravenous insulin infusion in the management of brittle diabetes: etiologic and therapeutic implications.
    Williams G; Pickup JC; Keen H
    Diabetes Care; 1985; 8(1):21-7. PubMed ID: 3971843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin treatment in adolescence.
    Vicens-Calvet E; Gussinyé M; Albisu MA; Potau N; Ibanez L
    J Endocrinol Invest; 1989; 12(8 Suppl 3):109-12. PubMed ID: 2681342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Results of follow-up of patients with diabetes mellitus type 1].
    Namazova LS; Antonova EV
    Sov Med; 1991; (4):65-8. PubMed ID: 1871638
    [No Abstract]   [Full Text] [Related]  

  • 15. Brittle diabetes in the young.
    Heller S
    Practitioner; 1992 Dec; 236(1521):1126-9. PubMed ID: 1369810
    [No Abstract]   [Full Text] [Related]  

  • 16. Mortality and outcome of patients with brittle diabetes and recurrent ketoacidosis.
    Kent LA; Gill GV; Williams G
    Lancet; 1994 Sep; 344(8925):778-81. PubMed ID: 7916072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A clinical algorithm to determine the etiology of brittle diabetes.
    Schade DS; Eaton RP; Drumm DA; Duckworth WC
    Diabetes Care; 1985; 8(1):5-11. PubMed ID: 3882369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and characteristics of brittle diabetes in Britain.
    Gill GV; Lucas S; Kent LA
    QJM; 1996 Nov; 89(11):839-43. PubMed ID: 8977963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes research: are we getting anywhere?
    Zinman B
    CMAJ; 1996 Nov; 155(9):1271-4. PubMed ID: 8911293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brittle diabetes revisited: the Third Arnold Bloom Memorial Lecture.
    Tattersall RB
    Diabet Med; 1997 Feb; 14(2):99-110. PubMed ID: 9047086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.